"The lifting of travel restrictions and another relaxation of testing requirements in February came as a much needed shot of medicine after the set-back of the Omicron variant", Hargreaves Lansdown analyst Susannah Streeter commented on Tuesday before the FTSE Russell announcement.
Neutral
Neutral
FTSE Russell
Neutral
Neutral
Hargreaves Lansdown